Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended January 31, 2003

 

Commission File Number 0-26670

 


 

NORTH AMERICAN SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

51-0366422

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

20200 Sunburst Street, Chatsworth, CA 91311

(Address of principal executive offices)

 

 

 

(818) 734-8600

(Registrant’s telephone number, including area code)

 


 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

ý Yes     o No

 

The number of shares of Registrant’s Common Stock, $.01 par value, outstanding as of March 7, 2003 was 10,254,418 shares.

 

 



 

NORTH AMERICAN SCIENTIFIC, INC.

 

Index

 

Part I – Financial Information

 

Item 1.

Financial Statements

 

 

 

 

 

Consolidated Balance Sheets as of January 31, 2003 and October 31, 2002

 

 

 

 

 

 

Consolidated Statements of Operations for the three months ended January 31, 2003 and 2002

 

 

 

 

 

 

Consolidated Statements of Cash Flows for the three months ended January 31, 2003 and 2002

 

 

 

 

 

 

Condensed Notes to the Consolidated Financial Statements

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

Part II – Other Information

 

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

Signatures

 

 

 

2



 

NORTH AMERICAN SCIENTIFIC, INC.

 

Consolidated Balance Sheets

 

 

 

January 31,
2003

 

October 31,
2002

 

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

2,713,000

 

$

2,708,000

 

Marketable securities

 

27,559,000

 

36,144,000

 

Accounts receivable

 

1,960,000

 

2,416,000

 

Inventories

 

794,000

 

596,000

 

Income taxes receivable

 

 

1,006,000

 

Prepaid expenses and other current assets

 

1,384,000

 

833,000

 

 

 

 

 

 

 

Total current assets

 

34,410,000

 

43,703,000

 

 

 

 

 

 

 

Non-current marketable securities

 

25,737,000

 

17,093,000

 

Equipment and leasehold improvements

 

3,419,000

 

3,264,000

 

Goodwill

 

3,659,000

 

3,659,000

 

Licenses and patents

 

361,000

 

469,000

 

Deferred income taxes

 

844,000

 

844,000

 

Other assets

 

103,000

 

103,000

 

 

 

 

 

 

 

Total assets

 

$

68,533,000

 

$

69,135,000

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

940,000

 

$

1,109,000

 

Accrued expenses

 

3,634,000

 

3,125,000

 

 

 

 

 

 

 

Total current liabilities

 

4,574,000

 

4,234,000

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred stock, $.01 par value, 2,000,000 shares authorized; no shares issued

 

 

 

Common stock, $.01 par value, 40,000,000 shares authorized; 10,263,418 and 10,250,136 shares issued and outstanding as of January 31, 2003 and October 31, 2002, respectively

 

103,000

 

103,000

 

Additional paid-in capital

 

74,014,000

 

73,929,000

 

Accumulated deficit

 

(10,158,000

)

(9,131,000

)

 

 

 

 

 

 

Total stockholders’ equity

 

63,959,000

 

64,901,000

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

68,533,000

 

$

69,135,000

 

 

See condensed notes to the consolidated financial statements.

 

3



 

NORTH AMERICAN SCIENTIFIC, INC.

 

Consolidated Statements of Operations

 

 

 

 

Three Months Ended
January 31,

 

 

 

2003

 

2002

 

 

 

(Unaudited)

 

 

 

 

 

 

 

Net sales

 

$

5,141,000

 

$

4,936,000

 

 

 

 

 

 

 

Cost of goods sold

 

1,843,000

 

1,772,000

 

 

 

 

 

 

 

Gross profit

 

3,298,000

 

3,164,000

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

2,415,000

 

1,224,000

 

Research and development

 

1,957,000

 

2,230,000

 

 

 

 

 

 

 

Loss from operations

 

(1,074,000

)

(290,000

)

 

 

 

 

 

 

Interest and other income, net

 

358,000

 

490,000

 

 

 

 

 

 

 

Income (loss) before provision for income taxes

 

(716,000

)

200,000

 

 

 

 

 

 

 

Provision for income taxes

 

 

74,000

 

 

 

 

 

 

 

Income (loss) before cumulative effect of change in accounting principle

 

(716,000

)

126,000

 

 

 

 

 

 

 

Cumulative effect of change in accounting principle (Note 6)

 

(311,000

)

 

 

 

 

 

 

 

Net income (loss)

 

$

(1,027,000

)

$

126,000